ETON - Eton Pharmaceuticals GAAP EPS of -$0.06 misses by $0.09 revenue of $7.4M misses by $0.36M August, 11 2022 04:03 PM Eton Pharmaceutcials Inc. Eton Pharmaceuticals press release ( NASDAQ: ETON ): Q2 GAAP EPS of -$0.06 misses by $0.09 . Revenue of $7.4M (+141.0% Y/Y) misses by $0.36M . For further details see: Eton Pharmaceuticals GAAP EPS of -$0.06 misses by $0.09, revenue of $7.4M misses by $0.36M